View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Carole Braudeau
  • Carole Braudeau

Credit Morning 05/17/2024

Cellnex issues € 750m of 2029 notes to redeem bank debt. S&P cuts the rating of ams OSRAM to B/stable from BB-/negative. Clariane : launch of two capital increases totalling €328m, including one reserved for HLD Europe. >...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 17/05/2024

Cellnex émet 750 m EUR d’obligations 01/2029 afin de rembourser de la dette bancaire. S&P dégrade le rating d’ams OSRAM de BB-/négative à B/stable. Clariane : lancement de deux augmentations de capital d’un montant total de 328 m EUR, dont une réservée à HLD Europe. >...

Research Department
  • Research Department

INFORME DIARIO 17 MAYO (ANÁLISIS BANCO SABADELL)

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CELLNEX, COLONIAL, FCC, MERLIN PROPERTIES, GRIFOLS, OHLA, SECTOR BANCARIO ESPAÑA. EUROPA: PROSUS. Respiro en las bolsas europeas Jornada de pérdidas moderadas en Europa, tras varios días de subidas que han llevado al STOXX 600 a máximos históricos y al Ibex a máximos de 2015, superando los 11.300 puntos. Dentro del STOXX 600, Seguros y R. Básicos mostraron el mejor comportamiento frente a las pérdidas de Autos e Industriales. Desde la macro, en la E...

Julian Dobrovolschi ... (+2)
  • Julian Dobrovolschi
  • Thomas Zlowodzki

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 05/15/2024

With 71% of the companies in the Stoxx 600 having released their Q1 2024 results, the picture at this stage is encouraging, with 58% of positive surprises on results. Materials and financials were the sectors that delivered the most positive surprises. If the Q4 2023 earnings season put an end to a downward revision of EPS, the Q1 2024 earnings season has triggered the start of an upward EPS revision, more markedly in the US than in Europe. In terms of sectors, re-rating effects conti...

Julian Dobrovolschi ... (+2)
  • Julian Dobrovolschi
  • Thomas Zlowodzki

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 15/05/2024

Alors que 71% des sociétés du Stoxx 600 ont publié, le bilan est à ce stade positif avec 58% de surprises positives sur les résultats. Matériaux et Financières sont les secteurs ayant apporté le plus de surprises positives. Le consensus – qui avait stoppé sa baisse durant les publications T4-23, est désormais reparti à la hausse, plus nettement aux Etats-Unis qu’en Europe. Sectoriellement, les effets de rerating ont continué de dominer les révisions de BPA. - ...

Ana Arjona-Martinez ... (+2)
  • Ana Arjona-Martinez
  • Antonio Rodriguez Vicens

ACS : Results and cash flow, both evolving largely as expected

>Results in line with our estimates, both at the P&L and the cash flow generation - The company’s Q1 2024 results were largely in line with our estimates once excluding the Hochtief results, already reported: Dragados, the main operating division outside Hochtief, and now part of the E&C division, showed EBITDA 1% ahead of our estimates, whilst the differences in net financial expenses, equity method, taxes and minorities were negligible and largely offsetting themse...

 PRESS RELEASE

BASF ranks 22 on Fair360 list of Top 50 Companies for Diversity

BASF ranks 22 on Fair360 list of Top 50 Companies for Diversity FLORHAM PARK, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- For the twelfth consecutive year, BASF has been named one of Fair360’s Top 50 Companies, ranking number 22 on the list in 2024. BASF was also recognized this year as a Top Company for Sponsorship, a Top Company for Latino Executives, and a Top Company for Executive Fairness Councils. Fair360 announced the 2024 list during its annual Top 50 Companies event on May 13, 2024, in New York City. "Diversity, equity and inclusion are fundamental to attracting and retaining the bes...

Luis Arredondo
  • Luis Arredondo

ACS: 1Q’24 RESULTS (ANÁLISIS BANCO SABADELL)

1Q'24 vs. 1Q'23 Results Sales: € 8.706 Bn (+7.3% vs. +4.0% BS(e) and +5.4% consensus); EBITDA: € 461.0 M (-0.2% vs. +0.7% BS(e) and +1.7% consensus); EBIT: € 327.0 M (-0.3% vs. +0.1% BS(e) and +1.5% consensus); Net Profit: € 177.0 M (+8.6% vs. -4.2% BS(e) and +1.2% consensus);

Luis Arredondo
  • Luis Arredondo

ACS: RDOS. 1T’24 (ANÁLISIS BANCO SABADELL)

Rdos. 1T'24 vs 1T'23: Ventas: 8.706 M euros (+7,3% vs +4,0% BS(e) y +5,4% consenso); EBITDA: 461,0 M euros (-0,2% vs +0,7% BS(e) y +1,7% consenso); EBIT: 327,0 M euros (-0,3% vs +0,1% BS(e) y +1,5% consenso); BDI: 177,0 M euros (+8,6% vs -4,2% BS(e) y +1,2% consenso).

Research Department
  • Research Department

INFORME DIARIO 14 MAYO + RDOS. ESPAÑA Y EUROPA 1T’24. PREVIEWS (ANÁLIS...

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACS, COLONIAL, FERROVIAL, GRIFOLS, LOGISTA, NH HOTELES, UNICAJA. EUROPA: BAYER. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 1T’24 que se publicarán en España y Europa en los próximos días. Jornada de transición en las bolsas En una sesión sin referencias macroeconómicas y con la campaña de resultados com...

Research Department
  • Research Department

IBERIAN DAILY 14 MAY + 1Q’24 RESULTS. PREVIEWS (ANÁLISIS BANCO SABADEL...

NEWS SUMMARY: ACS, COLONIAL, FERROVIAL, GRIFOLS, LOGISTA, NH HOTELES, SANTANDER, TELEFÓNICA, UNICAJA. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 1Q’24 results to be released over the coming days in Spain. A transition session for stock markets In a session without macroeconomic references and with the earnings season being the only catalyst, most European indices (with t...

Research Department
  • Research Department

INFORME DIARIO 13 MAYO + RDOS. ESPAÑA Y EUROPA 1T’24. IDEAS DESTACADAS...

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ALMIRALL, CELLNEX, GLOBAL DOMINION, GREENING, NATURGY. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 1T’24 que se publicarán en España y Europa en los próximos días. Semana de rebote en las bolsas Semana de rebote en las bolsas que se acercan a máximos del año después de que el Banco de Inglaterra allanase...

Research Department
  • Research Department

IBERIAN DAILY 13 MAY + 1Q’24 RESULTS. HIGHLIGHTS AND REST OF PREVIEWS ...

NEWS SUMMARY: ALMIRALL, CELLNEX, GLOBAL DOMINION, GREENING, NATURGY. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 1Q’24 results to be released over the coming days in Spain. Stock markets rallied last week Stock exchanges rallied last week, trading near annual highs after the Bank of England paved the way to initiate rate cuts next month and the governor Andrew Bailey stat...

 PRESS RELEASE

Press Release: Sanofi adds over €1 billion for biomanufacturing to €2....

Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty   Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty Paris, May 13, 2024. As the largest private contributor to the security and independence of France's health ecosystem, Sanofi today announces an investment of more than €1 billion to create new bioproduction capacity at its sites in Vitry-sur-Seine (Val de Marne), Le Trait (Seine-Maritime) a...

 PRESS RELEASE

Press Release: Sanofi and Novavax announce co-exclusive licensing agre...

Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines   Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines Agreement provides patients with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwards Accelerates potential for development of a novel flu-COVID-19 combination product based on authorized vaccines with ...

 PRESS RELEASE

Communiqué de presse : Sanofi et Novavax concluent un accord de licenc...

Communiqué de presse : Sanofi et Novavax concluent un accord de licence co-exclusif pour la co-commercialisation d’un vaccin COVID-19 et le développement de vaccins combinés grippe - COVID-19 Sanofi et Novavax concluent un accord de licence co-exclusif pour la co-commercialisation d’un vaccin COVID-19 et le développement de vaccins combinés grippe - COVID-19 L’accord, qui combinera la puissance commerciale des deux entreprises, permettra aux patients de bénéficier à partir de 2025 d’un meilleur accès à un vaccin adjuvanté à base de protéines, non-ARNm, contre la COVID-19 Accélération du ...

 PRESS RELEASE

Three BASF women in manufacturing honored at the 2024 Women MAKE Award...

Three BASF women in manufacturing honored at the 2024 Women MAKE Awards FLORHAM PARK, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Three BASF leaders in manufacturing were among recognized nationally at The Manufacturing Institute’s (MI) annual Women MAKE Awards. This national awards program identifies top talent in manufacturing and further encourages award winners to mentor and support the next generation of female talent to pursue modern manufacturing careers. BASF’s 2024 award winners include: Women MAKE Honoree: Paula Clark, Manager, Services & StrategyWomen MAKE Honoree: Katie Cook, TP...

Iberdrola S.A.: 1 director

A director at Iberdrola S.A. sold 40,000 shares at 11.490EUR and the significance rating of the trade was 85/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

 PRESS RELEASE

GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - avril ...

GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - avril 2024 Raison sociale de l'émetteur :BNP PARIBAS - SA au capital de 2.294.954.818 euros Immatriculée sous le n° 662 042 449 RCS Paris Siège social : 16, boulevard des Italiens, 75009 Paris Informations relatives au nombre total de droits de vote et d'actions prévues parl'article L.233-8 II du code de commerce et l'article 223-16 du règlement général de l'Autorité des Marchés Financiers  Date Nombre d'actions composant le capitalNombre total de droits de vote          30 avril 20241 147 477 4091 147 477 409         ...

Dominic Rose ... (+2)
  • Dominic Rose
  • Naresh Chouhan

Sanofi - The Path to €120 (BUY, TP EUR120 [110], 7pgs)

This new analysis shows how Sanofi shares get to €120 (+c.30%) by end 2025. We have conducted a foundational analysis that investors can refer to over the next 18mths as Sanofi releases at least 15 P2 & P3 pipeline readouts. We show the upside potential from every single readout and show that just 4 drugs could add €18/share upon successful readouts. In addition to multiple readouts, the likely Consumer Health spin in Q4, the tolebrutinib overhang being resolved one way or another and a strong C...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch